Rediscovering vitamin D

Libyan Journal of Medicine

Volumn 5, Issue 1, 2010, Pages

  Anaizi, Nasr ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Autoimmune; Calcidiol; Calcitriol; Cancer; Cardiovascular; Cathelicidin; Disease prevention; Mycobacterial infection; Vitamin D deficiency

Indexed keywords

EID: 84891588525     PISSN: 19932820     EISSN: 18196357     Source Type: Journal    
DOI: 10.3402/ljm.v5i0.5648     Document Type: Review

References (49)

1. History of Vitamin D. Available from: http://vitamind.ucr.edu/ history.html [cited 1 October 2010].
2. Unveiling the Enigma of Vitamin D. Available from: http:// www.beyonddiscovery.org/content/view.txt.asp?a-414 [cited 1 October 2010].
3. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357: 266-81.
4. Daniel D. Bikle. Endotext website. Chapter 3-Vitamin D: Production, metabolism, and mechanisms of action. Available from: http://www.endotext.org/parathyroid/parathyroid3/para thyroid3.htm [cited 1 October 2010].
5. Nabeshima Y. Discovery of alpha-Klotho unveiled new insights into calcium and phosphate homeostasis. Proc Jpn Acad Ser B Phys Biol Sci. 2009; 85: 125-41.
6. Masuda S, Byford V, Arabian A, Sakai Y, Demay MB, St-Arnaud R, et al. Altered pharmacokinetics of 1,25-dihydroxyvitamin D3 and 25-hydroxy vitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (CYP24A1) null mouse. Endocrinology 2005; 146: 825-34.
7. Köstner K, Denzer N, Müller CS, Klein R, Tilgen W, Reichrath J. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009; 29: 3511-36.
8. Bid HK, Mishra DK, Mittal RD. Vitamin-D receptor (VDR) gene (Fok-I, Taq-I & Apa-I) polymorphisms in healthy individuals from North Indian population. Asian Pac J Cancer Prev. 2005; 6: 147-52.
9. Larcombe LA, Orr PH, Lodge AM, Brown JS, Dembinski IJ, Milligan LC, et al. Functional gene polymorphisms in Canadian aboriginal populations with high rates of tuberculosis. J Infect Dis. 2008; 198: 1175-9.
10. Fleet JC. Vitamin D receptors: not just in the nucleus anymore. Nutr Rev. 1999; 57: 60-3.
11. Nemere I, Schwartz Z, Pedrozo H, Sylvia VL, Dean DD, Boyan BD. Identification of a membrane receptor for 1,25-dihydroxyvitamin D3 which mediates rapid activation of protein kinase C. J Bone Miner Res. 1998; 13: 1353-9.
12. Khanal R, Nemere I. Membrane receptors for vitamin D metabolites. Crit Rev Eukaryot Gene Expr. 2007; 17: 31-47.
13. Smolders J, Damoiseaux J, Menheere P, Hupperts R. Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol. 2008; 194: 7-17.
14. Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol. 2010; 9: 599-612.
15. Ben-Zvi I, Aranow C, Mackay M, Stanevsky A, Kamen DL, Marinescu LM, et al. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One. 2010; 5: e9193.
16. Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Endocrinol Metab Clin North Am. 2010; 39: 419-46.
17. Marjamäki L, Niinistö S, Kenward MG, Uusitalo L, Uusitalo U, Ovaskainen ML, et al. Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring. Diabetologia. 2010; 53: 1599-607.
18. Miller J, Gallo RL. Vitamin D and innate immunity. Dermatol Ther. 2010; 23: 13-22.
19. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature. 2007; 449: 819-26.
20. Kindt TJ, Goldsby RA, Osborne BA. Innate immunity. Chapter 3 in Kuby Immunology., 6th ed. NY: W.H. Freeman & Company; 2007.
21. Bartley J. Vitamin D, innate immunity and upper respiratory tract infection. J Laryngol Otol. 2010; 13: 1-5.
22. Gombart AF. The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol. 2009; 4: 1151-65.
23. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004; 173: 2909-12.
24. Schauber J, Dorschner RA, Coda AB, Buchau AS, Liu PT, Kiken D, et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest. 2007; 117: 803-11.
25. Krutzik SR, Hewison M, Liu PT, Robles JA, Stenger S, Adams JS, et al. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol. 2008; 181: 7115-20.
26. Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/ Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther. 2008; 324: 23-33.
27. Correale J, Ysrraelit MC, Gaitán MI. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain. 2009; 132: 1146-60.
28. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008; 88: 582S-6S.
29. Fiscella K, Franks P. Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann Fam Med. 2010; 8: 11-8.
30. Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc. 2009; 57: 1595-603.
31. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008; 168: 1174-80.
32. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency: an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008; 52: 1949-56.
33. Byers T. Anticancer vitamins du jour-The ABCED's so far. Am J Epidemiol. 2010; 172: 1-3.
34. Mohr SB, Garland CF, Gorham ED, Grant WB. Could ultraviolet B irradiance and vitamin D be associated with lower incidence rates of lung cancer? J Epidemiol Community Health. 2008; 62: 69-74.
35. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, et al. The role of vitamin D in cancer prevention. Am J Public Health. 2006; 96: 252-61.
36. Li H, Stampfer MJ, Hollis JB, Mucci LA, Gaziano JM, Hunter D, et al. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med. 2007; 4: e103.
37. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, et al. For Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006; 354: 684-96.
38. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007; 85: 1586-91.
39. International Agency for Research on Cancer (2008). Vitamin D and cancer. IARC Working Group Reports. Vol. 5. Lyon, France: International Agency for Research on Cancer. Available from: http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk5/Report-VitD.pdf [cited 27 November 2010].
40. Boscoe FP, Schymura MJ. Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002. BMC Cancer. 2006; 6: 264. Available from: http://www.ncbi. nlm.nih.gov/pmc/articles/PMC1665523/?tool=pubmed [cited 27 November 2010].
41. Grant WB. An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking. Int J Cancer. 2007; 120: 1123-8.
42. Tuohimaa P, Pukkala E, Scélo G, Olsen JH, Brewster DH, Hemminki K, et al. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer. 2007; 43: 1701-12.
43. Stolzenberg-Solomon RZ, Vieth R, Azad A, Pietinen P, Taylor PR, Virtamo J, et al. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res. 2006; 66: 10213-9.
44. Stolzenberg-Solomon RZ, Hayes RB, Horst RL, Anderson KE, Hollis BW, Silverman DT. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res. 2009; 69: 1439-47.
45. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, et al. Circulating 25-hydroxyvitamin D levels and risk of pancreatic cancer: cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol. 2010; 172: 81-93.
46. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006; 84: 18-28.
47. Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birthcohort study. Lancet. 2001; 358: 1500-3.
48. Heaney RP. The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol. 2005; 97: 13-9.
49. Brekke HK, Ludvigsson J. Vitamin D supplementation and diabetes-related autoimmunity in the ABIS study. Pediatr Diabetes. 2007; 8: 11-4.